These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19931605)

  • 1. Stabilization by meglumine of an amine compound degraded by formaldehyde in tablets.
    Fujita M; Ueda T; Iwata M
    Int J Pharm; 2010 Feb; 386(1-2):195-200. PubMed ID: 19931605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of formaldehyde by pharmaceutical excipients and its absorption by meglumine.
    Fujita M; Ueda T; Handa T
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1096-9. PubMed ID: 19801864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved synthesis of 3-(dialkylaminomethyl)-indole in acetic acid aqueous solution under ultrasound irradiation.
    Li JT; Sun SF; Sun MX
    Ultrason Sonochem; 2011 Jan; 18(1):42-4. PubMed ID: 20646952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
    Nassar MN; Nesarikar VN; Lozano R; Parker WL; Huang Y; Palaniswamy V; Xu W; Khaselev N
    Pharm Dev Technol; 2004; 9(2):189-95. PubMed ID: 15202578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.
    Wang G; Fiske JD; Jennings SP; Tomasella FP; Palaniswamy VA; Ray KL
    Pharm Dev Technol; 2008; 13(5):393-9. PubMed ID: 18720237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of melt granulation technology to enhance stability of a moisture sensitive immediate-release drug product.
    Kowalski J; Kalb O; Joshi YM; Serajuddin AT
    Int J Pharm; 2009 Oct; 381(1):56-61. PubMed ID: 19486933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
    Aryal S; Skalko-Basnet N
    Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of powder characteristics on oral tablet disintegration.
    Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution degradant of mirabegron extended release tablets resulting from a Strecker-like reaction between mirabegron, minute amounts of hydrogen cyanide in acetonitrile, and formaldehyde in PEG during sample preparation.
    Lin J; Huang T; Feng M; Li D; Zhao D; Wang J; Jin J; Zhu W; Li M
    J Pharm Biomed Anal; 2019 May; 168():181-188. PubMed ID: 30818256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of excipients and technological process on cholecalciferol stability and its liberation from tablets.
    Sawicka J
    Pharmazie; 1991 Jul; 46(7):519-21. PubMed ID: 1664519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of tricyclic antidepressants in formalin solutions.
    Takayasu T; Holterman K; Ohshima T; Pounder DJ
    J Forensic Sci; 1998 Nov; 43(6):1213-9. PubMed ID: 9846399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay.
    Huidobro AL; Rupérez FJ; Barbas C
    J Pharm Biomed Anal; 2007 Jun; 44(2):404-13. PubMed ID: 17250986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.